Blackberry Intake and Biomarkers of Cancer Risk
NCT01293617 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52
Last updated 2011-07-18
Summary
Berry components have been shown to influence cancer processes in cell culture studies. The investigators will conduct a study to investigate if blackberries influence the same cancer processes in a human feeding study.
Conditions
- Healthy Volunteers
Interventions
- OTHER
-
Blackberries
300 g blackberries daily for 5 days
- OTHER
-
Gelatin
300 g gelatin per day for 5 days
Sponsors & Collaborators
-
United States Department of Agriculture (USDA)
lead FED
Principal Investigators
-
Janet A Novotny, Ph.D. · Beltsville Human Nutrition Research Center, USDA
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2011-04-30
- Completion
- 2011-04-30
Countries
- United States
Study Locations
More Related Trials
-
Biomarkers for Oral Cancer
NCT00341497 ·Status: COMPLETED
-
Markers for Predicting Risk of Breast Cancer in Women of Different Races
NCT02574546 ·Status: WITHDRAWN
-
A Phase II Biomarker Trial of Gelatin Encapsulated Extract of American Ginseng Root (LEAG) in Breast Cancer
NCT00631852 ·Status: COMPLETED ·Phase: PHASE2
-
A Qualitative Exploration of the Impact of Positive BRCA1/2 Mutation Status on the Lives of Young Women
NCT00858078 ·Status: COMPLETED
-
Investigating Chemotherapy Treatments, Response and Subsets of HIV-associated Kaposi Sarcoma in Malawi
NCT03160183 ·Status: COMPLETED
-
Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants
NCT00900276 ·Status: COMPLETED
-
Biomarkers in Patients With Head and Neck Cancer and in Healthy Volunteers
NCT00899769 ·Status: COMPLETED
-
Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression
NCT01433224 ·Status: COMPLETED
-
Biomarker Analysis of Central Nervous System Tumors
NCT02692898 ·Status: TERMINATED
-
Cathepsin Activatable Fluorescent Probe
NCT01626066 ·Status: COMPLETED ·Phase: PHASE1
-
Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment
NCT00126867 ·Status: TERMINATED
-
Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx
NCT00899340 ·Status: COMPLETED
-
Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy
NCT00898430 ·Status: TERMINATED
-
Biomarkers in Samples From Young Patients With Soft Tissue Sarcoma
NCT01342783 ·Status: COMPLETED
-
Studying Genes Associated With Non-Hodgkin Lymphoma in Young Patients
NCT01623856 ·Status: COMPLETED
-
Biomarker Differences in Samples From Patients With Undifferentiated Sarcomas
NCT01802125 ·Status: COMPLETED
-
Memory Phenotype and PD-1 Inhibition Response in Oral Cancer
NCT03862066 ·Status: TERMINATED
-
Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study
NCT00323726 ·Status: WITHDRAWN
-
Early Detection of Gastric Cancer Using Plasma Cell-free DNA Fragmentomics
NCT05269056 ·Status: UNKNOWN
-
Blood Brain Barrier Differences in Patients with Brain Tumors Undergoing Surgery
NCT03071913 ·Status: COMPLETED
-
Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors
NCT07149207 ·Status: RECRUITING ·Phase: PHASE2
-
Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery
NCT02583269 ·Status: COMPLETED ·Phase: PHASE1
-
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
NCT03762733 ·Status: ENROLLING_BY_INVITATION
-
UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer
NCT00900094 ·Status: COMPLETED
-
Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer
NCT00898742 ·Status: TERMINATED